Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, metastatic malignant neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Active, not recruiting	Phase 1 / Phase 2	2025-09-02		NCT05669482

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Verastem, Inc.	24

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana Farber Cancer Institute	Boston	United States	133
Fred Hutchinson Cancer Center	Seattle	United States	250
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health	New York	United States	27
Memorial Sloan Kettering Cancer Center	New York	United States	1000
New York Presbyterian/Weill-Cornell Medical Center	New York	United States	1
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco	United States	22
University of Chicago	Chicago	United States	312
University of Michigan Cancer Center	Ann Arbor	United States	7
University of Pennsylvania	Philadelphia	United States	507
University of Utah Huntsman Cancer Institute	Salt Lake City	United States	15
Virginia Mason Medical Center	Seattle	United States	111
Washington University School of Medicine	St Louis	United States	895